Ind-swift gets nod for anti-infective
Ind-Swift has received the Drug Controller General of India's (DCGI) approval for manufacturing and marketing of the anti-infective drug Clarithromycin. To be sold under the trade name Clarie-SR,
Ind-Swift has received the Drug Controller General of India's (DCGI) approval for manufacturing and marketing of the anti-infective drug Clarithromycin. To be sold under the trade name Clarie-SR,